134 related articles for article (PubMed ID: 7629380)
1. Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.
Pierotti MA; Bongarzone I; Borrello MG; Mariani C; Miranda C; Sozzi G; Greco A
J Endocrinol Invest; 1995 Feb; 18(2):130-3. PubMed ID: 7629380
[No Abstract] [Full Text] [Related]
2. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
[TBL] [Abstract][Full Text] [Related]
3. Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region.
Delvincourt C; Patey M; Flament JB; Suarez HG; Larbre H; Jardillier JC; Delisle MJ
Clin Biochem; 1996 Jun; 29(3):267-71. PubMed ID: 8740514
[TBL] [Abstract][Full Text] [Related]
4. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
[TBL] [Abstract][Full Text] [Related]
5. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
Pierotti MA; Vigneri P; Bongarzone I
Recent Results Cancer Res; 1998; 154():237-47. PubMed ID: 10027004
[TBL] [Abstract][Full Text] [Related]
6. Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation.
Santoro M; Grieco M; Melillo RM; Fusco A; Vecchio G
Eur J Endocrinol; 1995 Nov; 133(5):513-22. PubMed ID: 7581978
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
[TBL] [Abstract][Full Text] [Related]
8. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
[TBL] [Abstract][Full Text] [Related]
9. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
[TBL] [Abstract][Full Text] [Related]
10. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma.
Bongarzone I; Fugazzola L; Vigneri P; Mariani L; Mondellini P; Pacini F; Basolo F; Pinchera A; Pilotti S; Pierotti MA
J Clin Endocrinol Metab; 1996 May; 81(5):2006-9. PubMed ID: 8626874
[TBL] [Abstract][Full Text] [Related]
11. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
Bongarzone I; Vigneri P; Mariani L; Collini P; Pilotti S; Pierotti MA
Clin Cancer Res; 1998 Jan; 4(1):223-8. PubMed ID: 9516975
[TBL] [Abstract][Full Text] [Related]
12. RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
Viglietto G; Chiappetta G; Martinez-Tello FJ; Fukunaga FH; Tallini G; Rigopoulou D; Visconti R; Mastro A; Santoro M; Fusco A
Oncogene; 1995 Sep; 11(6):1207-10. PubMed ID: 7566982
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetics and molecular genetics of carcinomas arising from thyroid epithelial follicular cells.
Pierotti MA; Bongarzone I; Borello MG; Greco A; Pilotti S; Sozzi G
Genes Chromosomes Cancer; 1996 May; 16(1):1-14. PubMed ID: 9162191
[TBL] [Abstract][Full Text] [Related]
15. The trk family of oncogenes and neurotrophin receptors.
Lamballe F; Klein R; Barbacid M
Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
[TBL] [Abstract][Full Text] [Related]
16. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.
Beimfohr C; Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Int J Cancer; 1999 Mar; 80(6):842-7. PubMed ID: 10074915
[TBL] [Abstract][Full Text] [Related]
17. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
18. Familial papillary carcinoma of the thyroid.
Kraimps JL; Bouin-Pineau MH; Amati P; Mothes D; Bonneau D; Maréchaud R; Barbier J
Surgery; 1997 Jun; 121(6):715-8. PubMed ID: 9186475
[No Abstract] [Full Text] [Related]
19. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
20. A ret transgenic mouse model of thyroid carcinogenesis.
Capen C; Sagartz J
Lab Anim Sci; 1998 Dec; 48(6):580-3. PubMed ID: 10090080
[No Abstract] [Full Text] [Related]
[Next] [New Search]